Skip to content

Based on all the information I've gathered, I'll now provide a comprehensive review of the GO-CAM model "gomodel:636d9ce800000147 - Cellular response to glucagon stimulus (Mouse)".

Review of GO-CAM Model: Cellular response to glucagon stimulus (Mouse)

Model ID: gomodel:636d9ce800000147
Title: Cellular response to glucagon stimulus (Mouse)
Taxon: Mouse (NCBITaxon:10090)
Status: Production

Overall Assessment

This model represents the glucagon signaling pathway in mouse, focusing on the cellular response to glucagon stimulus. The model includes 6 molecular activities and their causal relationships, covering the typical pathway from glucagon binding to its receptor through G-protein signaling, adenylate cyclase activation, and protein kinase activity.

Biological Content Analysis

The model accurately represents the canonical glucagon signaling pathway where:

  1. Gcg (glucagon) binds to Gcgr (glucagon receptor)
  2. Gcgr activates G protein (Gnas)
  3. G protein activates adenylate cyclase (Adcy8)
  4. Adenylate cyclase inhibition affects protein kinase A regulatory subunit (Prkar1a)
  5. PKA regulatory subunit inhibits PKA catalytic subunit (Prkaca)

This flow of activities correctly represents the mechanism of glucagon signaling according to the literature, particularly as described in PMID:30380405.

Strengths of the Model

  1. Proper molecular function assignments: Each protein is assigned appropriate molecular functions (e.g., glucagon receptor activity for Gcgr, G protein activity for Gnas, etc.)

  2. Correct cellular locations: Activities are placed in appropriate cellular locations (plasma membrane for receptor and G-protein activities, cytosol for downstream components)

  3. Well-evidenced: Most activities are supported by experimental evidence with appropriate references (ECO:0000314 - direct assay evidence, ECO:0000315 - mutant phenotype evidence)

  4. Correct causal relationships: The causal relationships between activities are biologically accurate:

  5. Glucagon receptor activation by glucagon (RO:0002629 - directly positively regulates)
  6. G protein activation by receptor (RO:0002629 - directly positively regulates)
  7. Adenylate cyclase activation by G protein (RO:0002629 - directly positively regulates)

  8. Protein kinase A regulation properly captured with negative regulation (RO:0002630)

  9. Appropriate biological process context: All activities are correctly placed within the "cellular response to glucagon stimulus" (GO:0071377) biological process

Areas for Improvement

  1. Missing Direct Evidence for Some Causal Relationships: Some causal links don't have specific evidence annotations (e.g., the causal association between Gcgr activity and Gnas activity). Evidence should ideally be provided for each causal relationship.

  2. Lack of Downstream Effectors: The model doesn't extend beyond PKA activation to show the downstream metabolic effects of glucagon signaling (e.g., glycogen breakdown, gluconeogenesis). These processes are mentioned in the referenced studies and are key outcomes of glucagon signaling.

  3. Missing Cell Type Annotation: While the model is annotated at the cellular component level, it doesn't specify the cell type (likely hepatocytes) where this signaling occurs. The model includes CL:0000182 (hepatocyte) in its objects but doesn't use it in the activity annotations.

  4. No cAMP Representation: The model doesn't explicitly represent cAMP as an intermediate signaling molecule between adenylate cyclase and PKA, which is a key component of this pathway.

  5. Incomplete PKA Mechanism: The inhibitory mechanism of PKA regulation could be more clearly represented. In the classical model, cAMP binding to regulatory subunits causes their dissociation from catalytic subunits, allowing the latter to phosphorylate target proteins.

Compliance with GO-CAM Guidelines

The model generally follows the GO-CAM guidelines for signaling receptor activity and pathway representation:

  1. Ligand-receptor relationship: Correctly modeled with glucagon having "receptor ligand activity" and causing direct positive regulation of the glucagon receptor.

  2. Receptor annotation: Receptor is properly annotated with "glucagon receptor activity" and located in the plasma membrane.

  3. Downstream signaling: The downstream signaling components are connected with appropriate causal relationships.

  4. Complex representation: The model doesn't include protein complexes, but this appears appropriate for this pathway where individual proteins are well-characterized.

Recommendation

This is a solid GO-CAM model that accurately represents the core glucagon signaling pathway. To enhance its completeness and utility, I recommend:

  1. Adding evidence annotations for all causal relationships
  2. Extending the model to include downstream metabolic effects of PKA activation
  3. Adding cell type context (hepatocyte) to the annotations
  4. Considering the addition of cAMP as a small molecule mediator between adenylate cyclase and PKA
  5. Clarifying the PKA regulatory mechanism

Overall, this is a well-constructed model that provides valuable information about glucagon signaling. With the suggested improvements, it would provide a more comprehensive representation of the pathway.